A detailed history of Thrivent Financial For Lutherans transactions in Glaukos Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 43,152 shares of GKOS stock, worth $6.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,152
Previous 41,813 3.2%
Holding current value
$6.75 Million
Previous $4.95 Million 13.6%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$113.62 - $135.39 $152,137 - $181,287
1,339 Added 3.2%
43,152 $5.62 Million
Q2 2024

Aug 13, 2024

SELL
$89.48 - $118.35 $46,708 - $61,778
-522 Reduced 1.23%
41,813 $4.95 Million
Q1 2024

May 14, 2024

SELL
$76.4 - $96.33 $82,359 - $103,843
-1,078 Reduced 2.48%
42,335 $3.99 Million
Q4 2023

Feb 14, 2024

SELL
$59.53 - $85.11 $65,006 - $92,940
-1,092 Reduced 2.45%
43,413 $3.45 Million
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $111,667 - $127,572
-1,613 Reduced 3.5%
44,505 $3.35 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $52,528 - $82,318
-1,156 Reduced 2.45%
46,118 $3.28 Million
Q1 2023

May 17, 2023

SELL
$43.88 - $52.48 $72,709 - $86,959
-1,657 Reduced 3.39%
47,274 $2.37 Million
Q4 2022

Feb 08, 2023

SELL
$40.82 - $57.75 $11,062 - $15,650
-271 Reduced 0.55%
48,931 $2.14 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $126,374 - $157,806
2,698 Added 5.8%
49,202 $2.62 Million
Q2 2022

Aug 16, 2022

BUY
$34.86 - $63.77 $290,453 - $531,331
8,332 Added 21.83%
46,504 $2.11 Million
Q1 2022

May 13, 2022

BUY
$44.33 - $57.82 $531 - $693
12 Added 0.03%
38,172 $2.21 Million
Q4 2021

Feb 16, 2022

BUY
$40.27 - $56.99 $21,101 - $29,862
524 Added 1.39%
38,160 $1.7 Million
Q3 2021

Nov 15, 2021

SELL
$47.43 - $84.23 $9,438 - $16,761
-199 Reduced 0.53%
37,636 $1.81 Million
Q2 2021

Aug 19, 2021

BUY
$73.06 - $97.7 $16,292 - $21,787
223 Added 0.59%
37,835 $3.21 Million
Q1 2021

May 17, 2021

BUY
$70.43 - $97.42 $27,960 - $38,675
397 Added 1.07%
37,612 $3.16 Million
Q4 2020

Feb 16, 2021

BUY
$48.9 - $75.26 $8,361 - $12,869
171 Added 0.46%
37,215 $2.8 Million
Q3 2020

Nov 10, 2020

BUY
$37.23 - $50.97 $138,681 - $189,863
3,725 Added 11.18%
37,044 $1.83 Million
Q2 2020

Aug 12, 2020

BUY
$28.78 - $46.83 $18,419 - $29,971
640 Added 1.96%
33,319 $1.28 Million
Q1 2020

May 15, 2020

BUY
$25.53 - $70.14 $834,294 - $2.29 Million
32,679 New
32,679 $1.01 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.44B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.